CIK 0001720580
- Non-accelerated filer
- Smaller reporting company
Adicet Bio, Inc.
Sign in to watch- Ticker
- ACET
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 26
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813305277
- Phone
- +1 617-482-2333
- Business address
- 131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
- Former names
- resTORbio, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 16,466 shares at $12.01 ($197,676)
- 4 Open-market sale President and CEO sold 16,466 shares at $13.04 ($214,700)
- 4 Open-market sale President and CEO sold 16,466 shares at an average $12.85 ($211,640)
- 4/A Open-market sale President and CEO sold 16,466 shares at an average $15.34 ($252,558)
- 4/A Shares withheld for taxes President and CEO gave up 8,649 shares (to pay taxes)
- 4 Open-market sale President and CEO sold 16,466 shares at an average $15.34 ($252,558)
- 4 Grant or award Chief Innovation Officer acquired 16,888 shares (grant or award)
- 4/A Derivatives Options or other derivatives
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 524,349 shares (grant or award)
- 4 Grant or award Director acquired 524,349 shares (grant or award)
- 4 Grant or award Director acquired 524,349 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 10 of 15 · 288 filings